BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31058349)

  • 1. BAP1-deficient tumor/nevus with germline aberration: A potential pitfall in assessing melanocytic neoplasms with single nucleotide polymorphism array.
    Hedayat AA; Lefferts JA; Atkinson AE; Busam KJ; Linos K
    J Cutan Pathol; 2019 Sep; 46(9):672-677. PubMed ID: 31058349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes.
    Busam KJ; Sung J; Wiesner T; von Deimling A; Jungbluth A
    Am J Surg Pathol; 2013 Feb; 37(2):193-9. PubMed ID: 23026932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome.
    Busam KJ; Wanna M; Wiesner T
    JAMA Dermatol; 2013 Mar; 149(3):335-9. PubMed ID: 23552620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z; Buljan M; Busam KJ
    J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of molecularly confirmed BAP1 inactivated melanocytic tumor with retention of immunohistochemical expression: A confounding factor.
    Linos K; Atkinson AE; Yan S; Tsongalis GJ; Lefferts JA
    J Cutan Pathol; 2020 May; 47(5):485-489. PubMed ID: 31891422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1-associated protein (BAP1)-inactivated melanocytic tumors.
    Zhang AJ; Rush PS; Tsao H; Duncan LM
    J Cutan Pathol; 2019 Dec; 46(12):965-972. PubMed ID: 31233225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAP1-deficient and VE1-negative atypical Spitz tumor.
    Requena C; Sanz V; Nagore E; García-Casado Z; Rubio L; Guillén C; Kutzner H
    J Cutan Pathol; 2015 Aug; 42(8):564-7. PubMed ID: 25953246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The morphologic spectrum of germline-mutated BAP1-inactivated melanocytic tumors includes lesions with conventional nevic melanocytes: A case report and review of literature.
    Wysozan TR; Khelifa S; Turchan K; Alomari AK
    J Cutan Pathol; 2019 Nov; 46(11):852-857. PubMed ID: 31206729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome.
    Louw A; Creaney J; Thomas A; Van Vliet C; Harvey NT; Wood BA; Mesbah Ardakani N
    Am J Dermatopathol; 2020 Nov; 42(11):872-875. PubMed ID: 32649346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.
    Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P
    J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating melanocytic lesions with single nucleotide polymorphism (SNP) chromosomal microarray.
    Hedayat AA; Linos K; Jung HS; Tafe LJ; Yan S; LeBlanc RE; Lefferts JA
    Exp Mol Pathol; 2017 Dec; 103(3):279-287. PubMed ID: 29169801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel insights into the BAP1-inactivated melanocytic tumor.
    Donati M; Martinek P; Steiner P; Grossmann P; Vanecek T; Kastnerova L; Kolm I; Baneckova M; Donati P; Kletskaya I; Kalmykova A; Feit J; Blasch P; Szilagyi D; Baldi A; Persichetti P; Crescenzi A; Michal M; Kazakov DV
    Mod Pathol; 2022 May; 35(5):664-675. PubMed ID: 34857909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature.
    Donati M; Šteiner P; Kazakov DV
    Am J Dermatopathol; 2023 Feb; 45(2):117-122. PubMed ID: 36669076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
    Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
    Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
    [No Abstract]   [Full Text] [Related]  

  • 15. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
    Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A
    Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline BRCA1-associated protein 1 mutation presenting as BAP1 inactivated melanocytic nevi in a child of a father with fatal paraganglioma.
    Watchorn RE; Calonje E; Taibjee SM
    Pediatr Dermatol; 2018 Sep; 35(5):e316-e318. PubMed ID: 29974497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambiguous melanocytic tumors with loss of 3p21.
    Yeh I; Mully TW; Wiesner T; Vemula SS; Mirza SA; Sparatta AJ; McCalmont TH; Bastian BC; LeBoit PE
    Am J Surg Pathol; 2014 Aug; 38(8):1088-95. PubMed ID: 24705312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.
    Wiesner T; Murali R; Fried I; Cerroni L; Busam K; Kutzner H; Bastian BC
    Am J Surg Pathol; 2012 Jun; 36(6):818-30. PubMed ID: 22367297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
    Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.